Skip to content

Clinical trials

Phase 1 Neuroblastoma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Phase: Phase 1 Country / region: United States Clear all

176 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20017
20026
20035
20047
20059
20066
20078
20083
20095
20109
201110
20125
20139
20148
20155
20169
20175
20185
20198
20205
20215
20223
20233
20242
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed109
Terminated22
Active, not recruiting20
Recruiting14
Withdrawn6
Unknown status3
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)30
New Approaches to Neuroblastoma Therapy Consortium17
Memorial Sloan Kettering Cancer Center16
Baylor College of Medicine10
St. Jude Children's Research Hospital10
Children's Oncology Group9
Emory University6
Dana-Farber Cancer Institute3
Giselle Sholler3
Milton S. Hershey Medical Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma176
Osteosarcoma49
Sarcoma41
Wilms Tumor37
Rhabdomyosarcoma35
Sarcoma, Ewing31
Medulloblastoma28
Neoplasms26
Recurrence22
Astrocytoma19

Trials

Showing 1 to 25 of 176. Each trial links to its page on Pharma Observatory.

76 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.